PMID: 2105887Feb 14, 1990Paper

A factor known to bind to endogenous Ig heavy chain enhancer only in lymphocytes is a ubiquitously active transcription factor

European Journal of Biochemistry
N ElmalehW Schaffner

Abstract

The transcriptional enhancer located in the first intron of the immunoglobulin heavy chain constant region is a major determinant of B-cell-specific expression of immunoglobulin genes. Like other enhancers, the Ig heavy chain enhancer contains several short sequence motifs that bind specific transcription factors. Each binding site contributes to the overall activity of the enhancer, however no single element seems absolutely required for activity. For a better understanding of the Ig heavy chain enhancer components, we have cloned and analyzed individual sequence elements. We find that the factor that binds to the E3 enhancer motif, CATGTGGC, is a ubiquitous transcription factor. It is present in an active form in both B cells and non-B cells, where it can mediate transcriptional activation in vitro and in vivo. However, despite its ability to activate transcription of a transfected reporter gene, the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non-lymphoid cells: In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3, was detected in B cells but not in non-B cells. From this and other findings the picture emerges that there are at least t...Continue Reading

References

May 5, 1988·Journal of Molecular Biology·G SchaffnerW Schaffner
Dec 1, 1986·Molecular and Cellular Biology·C L PetersonK L Calame
Apr 8, 1988·Cell·H Cedar
Jan 1, 1980·Methods in Enzymology·A M Maxam, W Gilbert
Apr 14, 1983·Nature·S Tonegawa
Jan 1, 1983·Annual Review of Biochemistry·W Doerfler
Jan 1, 1983·Progress in Clinical and Biological Research·M Busslinger, R A Flavell
Aug 1, 1983·Cell·M BusslingerR A Flavell
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·U Siebenlist, W Gilbert

❮ Previous
Next ❯

Citations

Feb 3, 2000·Molecular and Cellular Neurosciences·P ThatikuntaJ L Rutkowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.